Lee's Pharmaceutical Holdings Dividends and Buybacks
Dividend criteria checks 1/6
Lee's Pharmaceutical Holdings is a dividend paying company with a current yield of 2.16% that is well covered by earnings.
Key information
2.2%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | 2.2% |
| Dividend Growth | 5.7% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | HK$0.030 |
| Payout ratio | 28% |
Recent dividend and buyback updates
Lee's Pharmaceutical Holdings (HKG:950) Has Affirmed Its Dividend Of HK$0.01
May 21
Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01
May 21Recent updates
Lee's Pharmaceutical Holdings' (HKG:950) Earnings Are Weaker Than They Seem
Sep 04There's Reason For Concern Over Lee's Pharmaceutical Holdings Limited's (HKG:950) Price
Aug 07Lee's Pharmaceutical Holdings (HKG:950) Has Affirmed Its Dividend Of HK$0.01
May 21Optimistic Investors Push Lee's Pharmaceutical Holdings Limited (HKG:950) Shares Up 28% But Growth Is Lacking
Dec 20Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01
May 21Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01
Apr 02Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01
Aug 29Does Lee's Pharmaceutical Holdings (HKG:950) Have A Healthy Balance Sheet?
Apr 05Can Mixed Fundamentals Have A Negative Impact on Lee's Pharmaceutical Holdings Limited (HKG:950) Current Share Price Momentum?
Mar 17Should You Buy Lee's Pharmaceutical Holdings Limited (HKG:950) For Its 0.9% Dividend?
Feb 22What Type Of Returns Would Lee's Pharmaceutical Holdings'(HKG:950) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Jan 29Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 950's dividend payments have been volatile in the past 10 years.
Growing Dividend: 950's dividend payments have fallen over the past 10 years.
Dividend Yield vs Market
| Lee's Pharmaceutical Holdings Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (950) | 2.2% |
| Market Bottom 25% (HK) | 3.2% |
| Market Top 25% (HK) | 8.1% |
| Industry Average (Pharmaceuticals) | 3.8% |
| Analyst forecast (950) (up to 3 years) | 2.2% |
Notable Dividend: 950's dividend (2.16%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (3.23%).
High Dividend: 950's dividend (2.16%) is low compared to the top 25% of dividend payers in the Hong Kong market (8.08%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (28%), 950's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (123.2%), 950's dividend payments are not well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 06:38 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Lee's Pharmaceutical Holdings Limited is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jason Cheng | 3V Capital Limited |
| Yue-Kwong Lui | BOCOM International Securities Limited |
| Chu Wang | Citigroup Inc |